Deccan Health Care Ltd

Deccan Health Care Ltd has announced an Extra-Ordinary General Meeting (EGM) to be held on Friday, July 24, 2026, at 03:00 P.M. IST via Video Conferencing (VC)/Other Audio Visual Means (OAVM). The meeting will discuss and potentially pass special resolutions to regularize the appointment of Mr. Bhupendra Singh Kataria and Ms. Pratiksha Bisht as Non-Executive Independent Directors. The company is facilitating e-voting through NSDL, with the cut-off date for remote e-voting being July 17, 2026. Remote e-voting will commence on July 21, 2026, and close on July 23, 2026. The notice of the EGM is available on the company's website and the BSE website.

Deccan Health Care Limited announced the appointment of Mr. Tushar Mandal as Chief Financial Officer & Key Managerial Personnel, effective July 2, 2026. The decision was made by the Board of Directors during a meeting held on July 2, 2026, based on recommendations from the Nomination and Remuneration Committee and Audit Committee. Mr. Mandal has been with the company for over 8 years, overseeing financial operations. This appointment is subject to the terms and conditions of his employment.

Deccan Health Care Ltd has filed a revised resignation letter for Ms. Bhavika Sanghani, an Independent Director. The original resignation was dated June 26, 2026. The revised letter confirms no material reasons beyond personal and unavoidable circumstances. The resignation is now effective from June 29, 2026. The company has submitted this revised effective date and the updated resignation letter to the BSE as per SEBI regulations. Annexure-I details the reasons for change, date of cessation, and confirms no other directorships or relationships requiring disclosure.

Ms. Bhavika Sanghani has resigned as an Independent Director from the Board of Deccan Health Care Ltd, effective June 26, 2026. The resignation is due to personal and unavoidable circumstances. The company has submitted the necessary disclosures as per SEBI regulations. Ms. Sanghani does not hold directorships in any other listed entities.

Deccan Health Care Ltd announced the resignation of its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), Mr. Parth H Palera. His resignation is effective from the close of business hours on June 25, 2026, as he seeks better professional opportunities. Mr. Palera will also cease to be authorized for determining materiality of events and making disclosures to stock exchanges. The company has provided details as required by SEBI regulations.

Deccan Health Care Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from July 1, 2026, and will remain in effect for 48 hours after the announcement of the un-audited financial results for the quarter ended June 30, 2026. The company will communicate the date of the board meeting to consider these results in due course. Insiders and their relatives are reminded of their responsibility to comply with the company's insider trading code and refrain from trading during this period.

Deccan Health Care Ltd's Board of Directors approved the audited standalone and consolidated financial results for the fiscal year ended March 31, 2026, in a meeting held on May 30, 2026. The auditor's report, submitted by M/s Keyur Shah & Associates, Chartered Accountants, contains an unmodified opinion. The results will be available on the company's website.

Deccan Health Care Ltd announced its annual results for FY 2025-26, showcasing significant growth. Standalone revenue increased by 18.7% to ₹8,917.10 Lakhs, while profit after tax (PAT) surged by 91.2% to ₹229.04 Lakhs. Earnings per share (EPS) also saw a substantial rise of 66.1% to ₹0.93. Consolidated results showed a revenue increase of 9.1% to ₹8,190.48 Lakhs and a PAT increase of 114.7% to ₹248.76 Lakhs. The company highlighted its focus on innovation, preventive healthcare solutions, and expanding consumer reach through various channels.

Deccan Health Care Ltd's Board of Directors approved the standalone and consolidated audited financial results for the year ended March 31, 2026, during a meeting held on May 30, 2026. The auditor's report, submitted by M/s Keyur Shah & Associates, Chartered Accountants, contains an unmodified opinion. The results will be available on the company's website.

Deccan Health Care Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. The meeting will be held via VC/OAVM. The trading window for dealing in the company's securities has been closed since April 1, 2026, and will reopen 48 hours after the declaration of the financial results.